We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
(+1.3%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.06B |
| 2 |
UnitedHealth
UNH
|
+$935M |
| 3 |
Uber
UBER
|
+$426M |
| 4 |
Boeing
BA
|
+$312M |
| 5 |
Salesforce
CRM
|
+$309M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Meta Platforms (Facebook)
META
|
+$644M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$628M |
| 4 |
GE Vernova
GEV
|
+$439M |
| 5 |
Eli Lilly
LLY
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.14% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 8.46% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Pacira BioSciences
PCRX
$1.05B
| $803K | ﹤0.01% |
42,613
-482,336
| -92% | -$8.47M |
|
1802
Omnicell
OMCL
$1.96B
| $803K | ﹤0.01% |
18,029
-245,023
| -93% | -$11M |
|
1803
Edgewise Therapeutics
EWTX
$4.34B
| $798K | ﹤0.01% |
29,893
-547,672
| -95% | -$17.4M |
|
1804
BCE
BCE
$20.3B
| $798K | ﹤0.01% |
34,423
-19,281
| -36% | -$554K |
|
1805
Genco Shipping & Trading
GNK
$1.11B
| $797K | ﹤0.01% |
+57,181
| New | +$929K |
|
1806
Phathom Pharmaceuticals
PHAT
$930M
| $796K | ﹤0.01% |
+98,068
| New | +$1.21M |
|
1807
Babcock & Wilcox
BW
$1.31B
| $795K | ﹤0.01% |
484,903
+431,604
| +810% | +$913K |
|
1808
Logitech
LOGI
$16B
| $795K | ﹤0.01% |
9,604
-441,788
| -98% | -$36.6M |
|
1809
Medallion Financial
MFIN
$229M
| $793K | ﹤0.01% |
84,413
-5,732
| -6% | -$53.4K |
|
1810
Sibanye-Stillwater
SBSW
$5.93B
| $790K | ﹤0.01% |
239,519
-2,686,357
| -92% | -$11.3M |
|
1811
RCM Technologies
RCMT
$205M
| $790K | ﹤0.01% |
35,634
-22,039
| -38% | -$491K |
|
|
WCLD
1812
WisdomTree Cloud Computing Fund
WCLD
$265M
| $786K | ﹤0.01% |
+20,961
| New | +$762K |
|
|
ONT
1813
Onterris Inc
ONT
$740M
| $785K | ﹤0.01% |
42,294
-42,795
| -50% | -$900K |
|
|
ORGN
1814
DELISTED
Origin Materials
ORGN
| $783K | ﹤0.01% |
+20,396
| New | +$774K |
|
1815
Gaotu Techedu
GOTU
$384M
| $781K | ﹤0.01% |
+356,508
| New | +$1.04M |
|
1816
Franklin Electric
FELE
$4.85B
| $780K | ﹤0.01% |
8,005
-2,110
| -21% | -$220K |
|
1817
CALL
Walt Disney
DIS
$172B
| $779K | ﹤0.01% |
7,000
-8,200
| -54% | -$861K |
|
|
FSP
1818
Franklin Street Properties
FSP
$50.1M
| $778K | ﹤0.01% |
425,408
-228,663
| -35% | -$418K |
|
|
HTT
1819
High Templar Tech Ltd
HTT
$377M
| $774K | ﹤0.01% |
274,308
+84,532
| +45% | +$213K |
|
1820
Global X Cloud Computing ETF
CLOU
$231M
| $773K | ﹤0.01% |
+32,251
| New | +$737K |
|
|
HIMX
1821
Himax Technologies
HIMX
$2.09B
| $771K | ﹤0.01% |
95,952
-143,379
| -60% | -$904K |
|
1822
Bioventus
BVS
$895M
| $771K | ﹤0.01% |
73,423
-307,404
| -81% | -$3.64M |
|
|
SNCR
1823
DELISTED
Synchronoss Technologies
SNCR
| $770K | ﹤0.01% |
80,166
+28,551
| +55% | +$303K |
|
1824
Cardlytics
CDLX
$22.3M
| $768K | ﹤0.01% |
20,706
-64,689
| -76% | -$2.48M |
|
1825
Elbit Systems
ESLT
$38.4B
| $768K | ﹤0.01% |
2,976
-18,186
| -86% | -$4.27M |
|
Similar funds
Marshall Wace's Q4 2024 Portfolio in Review
As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
- Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
- Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
- Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
- Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
- Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.
Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.